PPRS: a positive for uptake?
Will the new pharmaceutical drug pricing scheme increase uptake and adoption of innovative medicines?
Outcomes: a gamechanger for pharma
Is the industry ready for patient-recorded outcome measures?
Visions 2014
Insights from the industry’s top thought leaders
Rare aware
The battle to overcome access barriers for orphan drugs continues to be a problem
The human touch
Just how useful are digital technologies and media in identifying the right people for the job?
New world marketing
PharmaTimes Magazine talks to this year’s Marketer of the Year winners about austerity, patient centricity and, of course, digital
Who understands value-based assessment?
Patients are finding their voice and demanding the power and influence they’ve been promised, says Phil Hammond
Business Insights from: Internis